Opens in a new tab

“Dear hair loss” – illness perceptions of female patients with chemotherapy-induced alopecia

Supportive Care in Cancer. 2022 May;30(5):3955-3963
Type:
Study
Link:
https://pubmed.ncbi.nlm.nih.gov/3504817…
PMID:
35048177
DOI:
10.1007/s00520-021-06748-y
Authors:

Anne Versluis, Kirsten van Alphen, Wouter Dercksen , Henk de Haas, Corina van den Hurk, Ad A Kaptein

Access Paper
1 Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. Anneversluis1@hotmail.com.
2 Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
3 Department of Medical Oncology, Máxima Medical Centre, Eindhoven, The Netherlands.
4 Department of Medical Psychology, Leiden University Medical Centre, Leiden, The Netherlands.

Related papers:

Abstract P5-08-10: Safety and Tolerability of Paxman Scalp Cooling at Lower Temperatures to Improve Efficacy with Anthracycline Chemotherapy

View

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

View

Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial

View

Abstract

Purpose

Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment. This study aims to assess the illness perceptions of female patients dealing with CIA, and their associations with demographic and clinical characteristics, coping strategies, and quality of life. The secondary aim was to compare the illness perceptions of patients with CIA with other samples, to help elucidate the specific perceptions of patients with CIA.

Methods

Forty female patients at risk of severe hair loss due to chemotherapy treatment were included at the oncological daycare unit of a teaching hospital in the Netherlands. Patients were asked to complete the Brief-Illness Perception Questionnaire (B-IPQ) and the Hair Quality of Life (Hair-QoL) questionnaire.

Results

Illness perceptions indicated that although patients understood their hair loss, they lacked being able to make sense of managing it, negatively impacting patients’ lives. Psychological quality of life was significantly correlated with the B-IPQ domains: consequences, degree of concern, and emotional response. Social quality of life was significantly correlated with psychological quality of life. Patients with CIA felt significantly less able to manage their hair loss, compared to patients with breast cancer and psoriatic arthritis.

Conclusion

As patients’ beliefs of being able to manage their hair loss are important for adopting and maintaining adequate coping behaviors, additional effort of health care providers in fostering patients’ sense of control is indicated, focusing on patients’ strengths during and after chemotherapy treatment. In the context of developing interventions for patients with CIA, consequences, concern, and emotional response are the major dimensions that should be taken in account to help patients deal with hair loss.

Keywords

  • Chemotherapy-induced alopecia
  • Common Sense Model
  • Coping
  • Illness perceptions
  • Psychological impact
  • Quality of life

Related papers

(pre-)Clinical research to understand alopecia and improve cooling results

• Authors: international multi-disciplinary special interest group (SIG) on chemotherapy-induced alopecia (CIA) & scalp cooling • Pathobiology of CIA is still not fully understood1 •…

View

A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention

Chemotherapy-induced alopecia (CIA) is the most visibly distressing side effect of commonly administered chemotherapeutic agents. Because psychological health has huge relevance to lifestyle, diet, and…

View

A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy

Alopecia is a distressing and common side-effect of chemotherapy, especially anthracycline- and taxane-containing regimen. A series of studies and reviews have considered scalp cooling as…

View
Get the Paxman System

Wherever you are in the world, it’s easy to give patients access to our chemotherapy side effect management solutions and a degree of control. Fill out the form to get started.

Get Paxman in your country with our global locator